Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/32732
Title: UroMark-a urinary biomarker assay for the detection of bladder cancer.
Authors: 
Keywords: 
Mesh: 
Issue Date: 2017
Citation: Clin Epigenetics.2017;(9):8
Abstract: Bladder cancer (BC) is one of the most common cancers in the western world and ranks as the most expensive to manage, due to the need for cystoscopic examination. BC shows frequent changes in DNA methylation, and several studies have shown the potential utility of urinary biomarkers by detecting epigenetic alterations in voided urine. The aim of this study is to develop a targeted bisulfite next-generation sequencing assay to diagnose BC from urine with high sensitivity and specificity.
PMID: 28163793
URI: https://hdl.handle.net/20.500.12530/32732
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. 12 de Octubre > Artículos

Files in This Item:
File Description SizeFormat 
PMC5282868.pdf3.16 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.